ESR1 and PIK3CA Polymorphisms as Potential Genetic Susceptibility Markers for Breast Cancer Risk in Bangladeshi Women: A Case‐Control Study
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/3651302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 30.07.2026. Verfasst von Mahim Hassan Chowdhury und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Lab, Rufaida BioMeds, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Breast Neoplasms, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is one of the most common and deadly cancers affecting women worldwide. This study is aimed at investigating the association between BC risk and two single nucleotide polymorphisms (SNPs): ESR1 (rs2234693) and PIK3CA (rs6443624) in a Bangladeshi population. A case‐control study was conducted with 112 BC patients and 124 healthy controls (HCs). Genomic DNA was extracted from peripheral blood samples, and genotyping was performed using polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP). Genotype and allele frequencies were analyzed to assess their association with BC risk. Genotype distributions for both ESR1 and PIK3CA conformed to Hardy–Weinberg equilibrium. The CT genotype of ESR1 was associated with a reduced risk of BC, whereas the CA genotype of PIK3CA was linked to an increased risk. The dominant model for ESR1 (CT + TT vs. CC) demonstrated a significant protective effect (aOR = 0.288, 95% CI: 0.160–0.516), whereas the dominant model for PIK3CA (CA + CC vs. AA) showed a higher risk (aOR = 4.166, 95% CI: 2.363–7.347). Over‐dominant models supported these findings, while recessive models for both SNPs showed no significant associations. The findings suggest that ESR1 ( rs2234693) may have a protective role and PIK3CA (rs6443624) may increase susceptibility to BC in Bangladeshi women. These SNPs may provide preliminary evidence for potential use as genetic susceptibility markers, but larger multicenter studies are needed before any clinical application can be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Lab, Rufaida BioMeds, Dhaka, Bangladesh.
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh, uap-bd.edu.
- School of Pharmacy, BRAC University, Dhaka, Bangladesh, bracu.ac.bd.
ORCID-Profile: Mahim Hassan Chowdhury, Nishat Tabassum Khusbu, Md Sharif Hossain, Mohiuddin Ahmed Bhuiyan, Md Aminul Haque
Zitieren
APA
Chowdhury, M. H., Shaolin, F. B., Khusbu, N. T., Puja, U. G., Hossain, M. S., Islam, M. R., Majumder, A., Hassan, S. M., Bhuiyan, M. A., & Haque, M. A. (2026). ESR1 and PIK3CA Polymorphisms as Potential Genetic Susceptibility Markers for Breast Cancer Risk in Bangladeshi Women: A Case‐Control Study. Human Mutation, 2026(1). https://doi.org/10.1155/humu/3651302
Vancouver
Chowdhury MH, Shaolin FB, Khusbu NT, Puja UG, Hossain MS, Islam MR, et al. ESR1 and PIK3CA Polymorphisms as Potential Genetic Susceptibility Markers for Breast Cancer Risk in Bangladeshi Women: A Case‐Control Study. Human Mutation. 2026;2026(1). doi:10.1155/humu/3651302
BibTeX
@article{Chowdhury2026,
author = {Chowdhury, Mahim Hassan and Shaolin, Faria Billal and Khusbu, Nishat Tabassum and Puja, Upama Gope and Hossain, Md Sharif and Islam, Md Robiul and Majumder, Akash and Hassan, Shah Musallin and Bhuiyan, Mohiuddin Ahmed and Haque, Md Aminul},
title = {ESR1 and PIK3CA Polymorphisms as Potential Genetic Susceptibility Markers for Breast Cancer Risk in Bangladeshi Women: A Case‐Control Study},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/3651302}
}
EUVIMED